Chronic rejection currently represents the main cause of failure in transplants worldwide, with immediate consequences for patients in terms of mortality, morbidity and costs for society. However, there are no robust evaluation systems available today to make accurate diagnoses and stratify the risks, which are key aspects in this field. In order to meet this need, the EU-TRAIN European project has the ambitious but realistic goal of offering clinicians innovative and accessible tools for the early prediction of individual risks of transplant rejection and personalizing clinical management and treatment so as to improve results. IDIBELL-HUB researchers led by Dr. Oriol Bestard received more than € 750,000 as partners of EU-TRAIN, which also involves the team of the renal transplant unit of HUB’s Nephrology Service.
